AstraZeneca inks pact with Research Society for Study of Diabetes in India1 min read . Updated: 26 Nov 2020, 07:05 PM IST
As a key facet of this association, the company has unveiled a three-year patient awareness programme, 'Beyond Sugar', developed to benefit over 1 crore people living with diabetes across the country, the company said
Drug firm AstraZeneca India on Thursday said it has signed a memorandum of understanding with the Research Society for Study of Diabetes in India (RSSDI) for driving awareness of diabetes among people to prevent complications arising from its uncontrolled incidence.
Select your Category